Laura A Gross, MD
Family Practice · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 17
- 3 carriers
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Looking this up.
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
17 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Gross’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
17 of 17 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A84043 · Current
Licensed to practise in California · since 2003 · expires 2027-01-31 · Saint Louis University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$8,401
Medicare paid this office $8,401 for 85 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 39 | $4,513 | $105 |
| Short return visit (20+ min) | 11 | $880 | $80 |
| Return visit (30+ min) | 11 | $789 | $72 |
Who their Medicare patients are
85 Original Medicare patients in 2024. Average age 70 · Under 65 20% · 85 and older 13% · Women 74% · Also on Medicaid 31% · Health risk score 1.38. Above the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 58% · Diabetes 31% · Coronary heart disease 24% · Chronic kidney disease 21% · Depression 21% · Atrial fibrillation 19% · Heart failure 16% · Cancer 13%.
The office billed $43,941, Medicare allowed $12,140 and paid $8,401; for 92 services of 10 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 85 | 92 | 70 | 1.38 | $43,941 | $8,401 |
| 2023 | 146 | 177 | 74 | 1.07 | $77,292 | $12,877 |
| 2022 | 160 | 221 | 73 | 1.31 | $88,589 | $16,655 |
| 2021 | 113 | 166 | 74 | 1.37 | $57,472 | $12,253 |
| 2020 | 98 | 125 | 72 | 1.56 | $41,940 | $7,709 |
| 2019 | 62 | 83 | 71 | 1.55 | $44,288 | $6,543 |
| 2018 | 73 | 91 | 71 | 1.43 | $43,856 | $5,565 |
| 2017 | 74 | 98 | 76 | 1.83 | $27,592 | $6,529 |
| 2016 | 139 | 244 | 78 | 1.19 | $41,994 | $14,562 |
| 2015 | 138 | 300 | 76 | 1.15 | $45,502 | $15,971 |
| 2014 | 100 | 178 | 76 | 1.00 | $35,104 | $11,042 |
| 2013 | 45 | 111 | 70 | 1.14 | $20,629 | $6,129 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Return visit (30+ min) | 42 | $4,844 | $108 |
| Return visit (30+ min) | 50 | $3,759 | $74 |
| Short return visit (20+ min) | 24 | $1,246 | $52 |
| Short return visit (20+ min) | 13 | $956 | $74 |
| Telehealth originating site facility fee | 18 | $409 | $23 |
2022: 6 services
| Return visit (30+ min) | 48 | $5,761 | $118 |
| Return visit (30+ min) | 35 | $3,022 | $86 |
| New patient visit (30+ min) | 14 | $1,368 | $98 |
| Short return visit (20+ min) | 14 | $1,086 | $78 |
| Telehealth originating site facility fee | 44 | $924 | $20 |
| New patient visit (30+ min) | 12 | $808 | $67 |
2021: 4 services
| Return visit (30+ min) | 30 | $3,657 | $118 |
| Return visit (30+ min) | 26 | $2,395 | $92 |
| Short return visit (20+ min) | 15 | $1,281 | $80 |
| Telehealth originating site facility fee | 40 | $827 | $21 |
2020: 5 services
| Return visit (30+ min) | 22 | $2,014 | $92 |
| Return visit (30+ min) | 18 | $1,255 | $70 |
| Short return visit (20+ min) | 15 | $1,022 | $68 |
| Short return visit (20+ min) | 16 | $729 | $46 |
| Telehealth originating site facility fee | 26 | $551 | $21 |
2019: 2 services
| Return visit (30+ min) | 34 | $3,767 | $99 |
| Return visit (30+ min) | 12 | $861 | $72 |
2018: 2 services
| Return visit (30+ min) | 37 | $3,377 | $82 |
| Short return visit (20+ min) | 15 | $652 | $43 |
2017: 2 services
| Return visit (30+ min) | 23 | $2,014 | $88 |
| Established patient custodial care facility, group care, or assisted living visit, typically 15 minutes | 11 | $1,090 | $47 |
2016: 4 services
| Return visit (30+ min) | 50 | $4,241 | $61 |
| Established patient custodial care facility, group care, or assisted living visit, typically 25 minutes | 23 | $2,896 | $85 |
| Short return visit (20+ min) | 47 | $2,320 | $43 |
| Established patient custodial care facility, group care, or assisted living visit, typically 15 minutes | 19 | $1,918 | $50 |
2015: 4 services
| Return visit (30+ min) | 68 | $6,723 | $65 |
| Short return visit (20+ min) | 52 | $4,282 | $42 |
| Established patient custodial care facility, group care, or assisted living visit, typically 15 minutes | 13 | $1,206 | $52 |
| Short return visit | 14 | $296 | $20 |
2014: 2 services
| Return visit (30+ min) | 47 | $4,524 | $64 |
| Short return visit (20+ min) | 43 | $2,718 | $43 |
2013: 2 services
| Return visit (30+ min) | 25 | $2,380 | $61 |
| Short return visit (20+ min) | 29 | $2,286 | $39 |
Drugs they prescribed that Part D paid
$75,856
Pharmacies billed $75,856 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 3% of their Part D prescriptions (25 of 940) in 2024. Above the middle of the specialty; the typical family practice clinician is at 2%. Long-acting opioids: 44% of their opioid prescriptions.
816 generic and fewer than 11 brand-name prescriptions · $75,856 in drug cost · 32 antibiotic prescriptions to 26 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Atorvastatin | 71 | $799 | $11 |
| Gabapentin | 21 | $686 | $33 |
| Losartan | 51 | $610 | $12 |
| Levothyroxine | 35 | $500 | $14 |
| Amlodipine Besylate | 48 | $486 | $10 |
See all 19 drugs
| Atorvastatin | 71 | $799 | $11 |
| Gabapentin | 21 | $686 | $33 |
| Losartan | 51 | $610 | $12 |
| Levothyroxine | 35 | $500 | $14 |
| Amlodipine Besylate | 48 | $486 | $10 |
| Rosuvastatin | 25 | $394 | $16 |
| Metoprolol | 18 | $369 | $21 |
| Fluticasone Propionate | 31 | $334 | $11 |
| Tamsulosin | 13 | $270 | $21 |
| Omeprazole | 15 | $246 | $16 |
| Metformin Hcl Er | 30 | $173 | $6 |
| Simvastatin | 13 | $161 | $12 |
| Ketoconazole | 14 | $156 | $11 |
| Pantoprazole | 12 | $148 | $12 |
| Metformin | 26 | $115 | $4 |
| Carvedilol | 11 | $114 | $10 |
| Alendronate | 12 | $99 | $8 |
| Hydrochlorothiazide | 17 | $94 | $6 |
| Lisinopril | 15 | $63 | $4 |
Year by year
| 2024 | 940 | 369 | 3% (25) | None | $75,856 |
| 2023 | 423 | 259 | 6% (26) | None | $36,954 |
| 2022 | 74 | 54 | 0% (0) | 15% | $3,338 |
| 2021 | 37 | 34 | 0% (0) | None | $2,038 |
| 2020 | 40 | 38 | None | None | $493 |
| 2019 | 46 | 32 | 0% (0) | 28% | $1,159 |
| 2018 | 47 | 25 | 0% (0) | None | $1,277 |
| 2017 | 375 | 53 | None | 16% | $22,231 |
| 2016 | 1,368 | 116 | 4% (56) | 23% | $121,235 |
| 2015 | 1,307 | 118 | 6% (74) | 21% | $102,524 |
| 2014 | 1,056 | 99 | 5% (54) | None | $67,350 |
| 2013 | 1,232 | 81 | 9% (113) | 23% | $65,275 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 5 drugs
| Nitrofurantoin Mono-Macro | 15 | $263 | $18 |
| Atorvastatin | 18 | $209 | $12 |
| Levothyroxine | 17 | $199 | $12 |
| Amlodipine Besylate | 22 | $175 | $8 |
| Metformin | 11 | $127 | $12 |
2017: 9 drugs
| Novolog Flexpen | 14 | $1,608 | $115 |
| Digox | 36 | $534 | $15 |
| Levothyroxine | 30 | $413 | $14 |
| Gabapentin | 22 | $321 | $15 |
| Mirtazapine | 22 | $279 | $13 |
| Polyethylene Glycol 3350 | 12 | $264 | $22 |
| Omeprazole | 18 | $163 | $9 |
| Lisinopril | 12 | $132 | $11 |
| Amlodipine Besylate | 11 | $56 | $5 |
2016: 41 drugs
| Xifaxan | 17 | $21,108 | $1,242 |
| Lantus | 16 | $4,378 | $274 |
| Flovent Hfa | 11 | $3,942 | $358 |
| Spiriva | 11 | $3,805 | $346 |
| Proctozone-Hc | 13 | $1,475 | $113 |
| Levothyroxine | 51 | $1,414 | $28 |
| Gabapentin | 59 | $1,357 | $23 |
| Novolog Flexpen | 11 | $1,206 | $110 |
| Proair Hfa | 12 | $648 | $54 |
| Digox | 17 | $575 | $34 |
| Hydrocodone-Acetaminophen | 25 | $493 | $20 |
| Omeprazole | 38 | $473 | $12 |
| Warfarin | 29 | $410 | $14 |
| Atorvastatin | 26 | $379 | $15 |
| Clonazepam | 16 | $329 | $21 |
| Spironolactone | 20 | $317 | $16 |
| Escitalopram | 17 | $314 | $18 |
| Amitriptyline | 20 | $308 | $15 |
| Simvastatin | 36 | $301 | $8 |
| Furosemide | 47 | $292 | $6 |
| Mirtazapine | 22 | $292 | $13 |
| Amlodipine Besylate | 39 | $283 | $7 |
| Lisinopril | 37 | $259 | $7 |
| Prednisone | 14 | $233 | $17 |
| Fluticasone Propionate | 19 | $226 | $12 |
| Acetylcysteine | 12 | $217 | $18 |
| Losartan | 19 | $202 | $11 |
| Metformin | 20 | $200 | $10 |
| Polyethylene Glycol 3350 | 12 | $177 | $15 |
| Ondansetron | 17 | $138 | $8 |
| Risperidone | 12 | $133 | $11 |
| Albuterol Sulfate | 11 | $129 | $12 |
| Metoprolol | 19 | $128 | $7 |
| Citalopram Hbr | 18 | $101 | $6 |
| Sertraline | 14 | $99 | $7 |
| Donepezil | 14 | $99 | $7 |
| Tramadol | 14 | $95 | $7 |
| Paroxetine | 12 | $95 | $8 |
| Atenolol | 13 | $94 | $7 |
| Quetiapine | 12 | $90 | $7 |
| Methadone | 11 | $86 | $8 |
2015: 41 drugs
| Xifaxan | 26 | $14,176 | $545 |
| Amitiza | 11 | $6,980 | $635 |
| Lantus | 21 | $5,676 | $270 |
| Flovent Hfa | 13 | $4,913 | $378 |
| Eliquis | 11 | $3,626 | $330 |
| Novolog | 12 | $2,870 | $239 |
| Duloxetine | 20 | $2,762 | $138 |
| Gabapentin | 77 | $2,450 | $32 |
| Levothyroxine | 58 | $1,267 | $22 |
| Proair Hfa | 15 | $859 | $57 |
| Metoprolol | 24 | $786 | $33 |
| Tamsulosin | 15 | $785 | $52 |
| Digox | 12 | $713 | $59 |
| Omeprazole | 48 | $647 | $13 |
| Hydrocodone-Acetaminophen | 33 | $609 | $18 |
| Atorvastatin | 34 | $572 | $17 |
| Carbidopa-Levodopa | 13 | $498 | $38 |
| Sumatriptan | 12 | $494 | $41 |
| Warfarin | 17 | $403 | $24 |
| Potassium Chloride | 17 | $387 | $23 |
| Polyethylene Glycol 3350 | 15 | $349 | $23 |
| Mirtazapine | 32 | $346 | $11 |
| Simvastatin | 40 | $327 | $8 |
| Amitriptyline | 14 | $286 | $20 |
| Lovastatin | 14 | $265 | $19 |
| Losartan | 26 | $265 | $10 |
| Hydrochlorothiazide | 37 | $249 | $7 |
| Metformin | 19 | $239 | $13 |
| Diltiazem 24hr Cd | 12 | $217 | $18 |
| Furosemide | 28 | $159 | $6 |
| Metoprolol | 21 | $148 | $7 |
| Lisinopril | 22 | $134 | $6 |
| Amlodipine Besylate | 19 | $130 | $7 |
| Spironolactone | 11 | $125 | $11 |
| Triamterene-Hydrochlorothiazid | 12 | $92 | $8 |
| Atenolol | 12 | $85 | $7 |
| Clonazepam | 16 | $84 | $5 |
| Sertraline | 11 | $70 | $6 |
| Tramadol | 18 | $43 | $2 |
| Trazodone | 13 | $38 | $3 |
| Alprazolam | 11 | $22 | $2 |
2014: 30 drugs
| Xifaxan | 23 | $9,917 | $431 |
| Amitiza | 12 | $6,408 | $534 |
| Lantus | 24 | $5,501 | $229 |
| Gabapentin | 52 | $1,716 | $33 |
| Levothyroxine | 58 | $1,089 | $19 |
| Sumatriptan | 15 | $974 | $65 |
| Digox | 17 | $822 | $48 |
| Metoprolol | 26 | $726 | $28 |
| Omeprazole | 34 | $708 | $21 |
| Fluticasone Propionate | 21 | $532 | $25 |
| Carbidopa-Levodopa | 14 | $448 | $32 |
| Simvastatin | 47 | $443 | $9 |
| Atorvastatin | 21 | $416 | $20 |
| Hydrocodone-Acetaminophen | 24 | $339 | $14 |
| Losartan | 13 | $303 | $23 |
| Mirtazapine | 16 | $283 | $18 |
| Warfarin | 48 | $281 | $6 |
| Lovastatin | 11 | $227 | $21 |
| Diltiazem 24hr Cd | 12 | $217 | $18 |
| Potassium Chloride | 12 | $196 | $16 |
| Generlac | 15 | $187 | $12 |
| Metformin | 13 | $155 | $12 |
| Hydrochlorothiazide | 40 | $132 | $3 |
| Metoprolol | 19 | $131 | $7 |
| Lisinopril | 17 | $119 | $7 |
| Citalopram Hbr | 16 | $112 | $7 |
| Triamterene-Hydrochlorothiazid | 13 | $100 | $8 |
| Methadone | 11 | $96 | $9 |
| Sertraline | 12 | $80 | $7 |
| Furosemide | 17 | $53 | $3 |
2013: 39 drugs
| Xifaxan | 33 | $9,494 | $288 |
| Oxycontin | 26 | $5,819 | $224 |
| Lantus | 28 | $4,951 | $177 |
| Gabapentin | 50 | $970 | $19 |
| Sumatriptan | 11 | $801 | $73 |
| Atorvastatin | 23 | $788 | $34 |
| Levothyroxine | 69 | $689 | $10 |
| Omeprazole | 49 | $655 | $13 |
| Metoprolol | 14 | $601 | $43 |
| Oxybutynin Chloride Er | 11 | $484 | $44 |
| Lovastatin | 29 | $454 | $16 |
| Hydrocodone-Acetaminophen | 50 | $452 | $9 |
| Fluticasone Propionate | 17 | $417 | $25 |
| Liothyronine | 11 | $408 | $37 |
| Carbidopa-Levodopa | 16 | $340 | $21 |
| Simvastatin | 34 | $337 | $10 |
| Donepezil | 11 | $316 | $29 |
| Metformin | 21 | $306 | $15 |
| Mirtazapine | 14 | $296 | $21 |
| Warfarin | 52 | $294 | $6 |
| Digox | 16 | $259 | $16 |
| Diltiazem 24hr Cd | 13 | $216 | $17 |
| Metoprolol | 35 | $214 | $6 |
| Potassium Chloride | 16 | $208 | $13 |
| Amlodipine Besylate | 18 | $195 | $11 |
| Famotidine | 12 | $142 | $12 |
| Glimepiride | 19 | $133 | $7 |
| Lisinopril | 19 | $125 | $7 |
| Zolpidem | 21 | $105 | $5 |
| Citalopram Hbr | 13 | $98 | $8 |
| Triamterene-Hctz | 20 | $97 | $5 |
| Enalapril Maleate | 12 | $92 | $8 |
| Lorazepam | 20 | $90 | $4 |
| Propranolol | 11 | $72 | $7 |
| Atenolol | 11 | $72 | $7 |
| Clonazepam | 13 | $63 | $5 |
| Digoxin | 12 | $61 | $5 |
| Hydrochlorothiazide | 18 | $58 | $3 |
| Furosemide | 12 | $51 | $4 |
Money from drug and device companies
$42 in 2025
| 2025 | 1 | 2 | None | $42 |
| 2023 | 1 | 1 | None | $22 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Grifols USA | Xembify | $42 | 2 payments
|
See all 2 published payments
| Grifols USA | Meals · 2025-10-30 | Xembify | $28 |
| Grifols USA | Meals · 2025-07-22 | Xembify | $14 |
See earlier years (2023)
2023: $22
| CSL Behring | Hizentra | $22 | 1 payment
|
Professional record
- NPI
- 1801932272
- Licence
- CA A84043California A84043: Current · expires 2027-01-31
- Trained
- Saint Louis University School of Medicine, 2001
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2007-01-30
- NPI last updated
- 2024-04-26
- NPI record certified
- 2024-04-26
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 2500 Alhambra Ave, Martinez, CA, 94553 · 50 Douglas Dr, Martinez, CA, 94553